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ABSTRACT
Objectives Health-related quality of life (HRQOL) is 
a key indicator of health. However, HRQOL data from 
representative populations in South Asia are lacking. This 
study aims to describe HRQOL overall, by age, gender 
and socioeconomic status, and examine the associations 
between selected chronic conditions and HRQOL in adults 
from three urban cities in South Asia.
Methods We used data from 16 287 adults aged 
≥20 years from the baseline survey of the Centre for 
Cardiometabolic Risk Reduction in South Asia cohort 
(2010–2011). HRQOL was measured using the European 
Quality of Life Five Dimension—Visual Analogue Scale 
(EQ5D-VAS), which measures health status on a scale of 0 
(worst health status) to 100 (best possible health status).
Results 16 284 participants completed the EQ5D-VAS. 
Mean age was 42.4 (±13.3) years and 52.4% were 
women. 14% of the respondents reported problems 
in mobility and pain/discomfort domains. Mean VAS 
score was 74 (95% CI 73.7 to 74.2). Significantly lower 
health status was found in elderly (64.1), women (71.6), 
unemployed (68.4), less educated (71.2) and low-income 
group (73.4). Individuals with chronic conditions reported 
worse health status than those without (67.4 vs 76.2): 
prevalence ratio, 1.8 (95% CI 1.61 to 2.04).
Conclusions Our data demonstrate significantly lower 
HRQOL in key demographic groups and those with chronic 
conditions, which is consistent with previous studies. 
These data provide insights on inequalities in population 
health status, and potentially reveal unmet needs in the 
community to guide health policies.
InTROduCTIOn
Health-related quality of life (HRQOL) is 
a multidimensional concept that provides 
a broader perspective of health through 
conveying an individual’s ability to function 
in physical, mental and social domains of 
life.1 HRQOL is thus an essential patient-cen-
tred outcome measure that is useful to guide 
health policies.2 3 HRQOL is preferred over 
other health indicators (life expectancy, 
mortality, morbidity) for measuring chronic 
disease burden as it incorporates both length 
and quality of life.4 In South Asia, chronic 
conditions (diabetes, hypertension and 
heart diseases) occur at an early age,5 with 
detrimental effects on length and quality 
of life.6 7 In addition, episodes and fear of 
hypoglycaemia, recurrent heart attacks, 
stroke and other long-term complications 
(kidney diseases, diabetic retinopathy) are 
not always measured as such, although they 
have a substantial adverse impact on an indi-
vidual’s overall health status.8 Therefore, it is 
important to quantify the effect of chronic 
conditions on individuals’ HRQOL.
Strengths and limitations of this study
 ► This is the first population-level health-related 
quality of life (HRQOL) data from South Asia using 
the European Quality of Life Five Dimension—Visual 
Analogue Scale  including three large metropolitan 
cities in India and Pakistan with a large sample size 
(16 284 adults aged ≥20 years).
 ► Our data provide the first baseline values to be 
used for monitoring population health status and 
analysed the relationships between selected chronic 
conditions and HRQOL.
 ► HRQOL data presented in this article could be used 
to complement national health targets by providing 
a measure of chronic disease burden based on 
perceived health status rather than solely on 
mortality and disease prevalence.
 ► Due to the cross-sectional nature of the data, 
the causal relationship between socioeconomic 
parameters or chronic conditions and HRQOL cannot 
be determined.
 ► Many chronic conditions (respiratory, locomotor, 
cancer and others) were not included in the survey. 
Therefore, the ranking of most severe health 
conditions and associated HRQOL is not complete.
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There are several disease-specific (Chronic Respira-
tory Distress Questionnaire, Arthritis Impact Measure-
ment Scale) and generic instruments (Short Form 36, 
WHO—Quality of Life Questionnaire and the Euro-
pean Quality of Life Five Dimension—Visual Analogue 
Scale (EQ5D-VAS)) available to measure population 
HRQOL.4 9–18 However, the EQ5D-VAS is favoured 
because it is generic, not specific to a particular disease, 
and it includes multidimensional measures of health 
profile in five dimensions (mobility, self-care, usual activ-
ities, pain/discomfort and anxiety/depression) and the 
single-dimensional measure VAS to summarise overall 
health status.1 Also, EQ5D-VAS has been applied and vali-
dated for its use in many population surveys across the 
world; therefore, it makes the comparison of health status 
across populations easier.
Data on population HRQOL across socioeconomic 
status (SES) from South Asia are scarce, and little is known 
about the relative associations between different chronic 
conditions and individual HRQOL. The Centre for 
Cardiometabolic Risk Reduction in South Asia (CARRS) 
study19 had collected data on both EQ5D-VAS and selected 
chronic conditions from a large representative popula-
tion of adults in urban South Asia. We used this oppor-
tunity to examine population HRQOL in this region. In 
this paper, we describe the variations in HRQOL by age, 
gender and SES, and explore the relationships between 
selected chronic conditions and HRQOL in a represen-
tative sample of adults aged ≥20 years from three metro-
politan cities in India and Pakistan. We also analysed the 
relationship between multidimensional EQ5D measures 
and single-dimensional VAS across major subgroups.
MeThOdS
Study design and setting
We obtained data from the baseline cross-sectional survey 
of the CARRS cohort (2010–2011), which recruited a 
representative sample of non-pregnant adults aged ≥20 
years from three urban cities: Chennai, Delhi and 
Karachi. These metropolitan cities with large and hetero-
geneous populations in terms of demographic profile 
and economic transitions offer unique opportunities to 
assess variations in health status across different socio-
economic groups. The detailed CARRS study design 
has been published elsewhere.19 Briefly, a multistage 
cluster random sampling strategy was used with wards 
(in Delhi and Chennai) or clusters (in Karachi) as the 
primary sampling units. Using the WHO STEPS (STEP-
wise approach to surveillance) survey ‘Kish method’, two 
participants, one male and one female, aged ≥20 years 
(non-pregnant) and meeting the study eligibility criteria, 
were selected from each randomly selected household.19
Study measures
Comprehensive and uniform data collection instru-
ments were used to capture measurements in all three 
sites. A summary of all surveillance measures, methods 
and instruments used in the study has been published 
in detail.19 Briefly, a questionnaire was administered to 
collect information regarding demographic, socioeco-
nomic, behavioural, and past and present health status of 
the participant.
Trained study staff measured anthropometric parame-
ters (height, weight) using standardised techniques and 
blood pressure (BP) twice at each participant’s home or at 
a medical camp organised in the community, after 5 min 
in a seated position using an electronic BP measuring 
device (Omron Dalian, Liaoning Sheng, China). If the 
difference between the first two systolic or diastolic BP 
readings was more than 10 mm Hg or 5 mm Hg, respec-
tively, a third reading was taken. Average BP readings 
of the two/three readings were recorded in the study 
database. Additionally, fasting blood glucose (FBG) and 
glycated haemoglobin (HbA1c) were measured. The 
overall response rates were 94.7% for questionnaire 
completion and 84.3% for blood tests.
Population health status was measured using the 
EQ5D-VAS questionnaire, which consisted of two compo-
nents: health state description and self-rated health status 
on VAS. Health state description (profile) includes five 
dimensions (5D): mobility (walking ability), self-care 
(ability to wash or dress by oneself), usual activities 
(ability to work, study, housework), pain/discomfort and 
anxiety/depression. The respondents self-rate their level 
of severity for each dimension using three levels (EQ5D-
3L): having no problems, having some or moderate 
problems, or being unable to do/having extreme prob-
lems. The respondents were asked to choose one of the 
statements that best described their health status on 
the surveyed day. For example, three levels of ‘mobility’ 
dimension were phrased as ‘I have no problems in 
walking’, ‘I have some problems in walking’ and ‘I am 
confined to bed’. Given the possible permutations of 
different domains and response types, there are poten-
tially 243 (=35) different health profiles.
For overall health status, the respondents evaluated 
their health status using the VAS. The VAS asks respon-
dents to mark health status on the day of the interview on 
a scale of 0 (worst health status) to 100 (best imaginable 
health status).
Covariates
Self-reported age at baseline in completed years was used 
and categorised into 20–24, 25–34, 35–44, 45–54, 55–64, 
65–74 and ≥75. Based on participant responses, we cate-
gorised employment status into employed, student, house-
wife, retired and unemployed. Income class was grouped 
into three categories based on household monthly income: 
low-income, less than 10 000 Indian rupees (equivalent to 
US$200); middle-income, 10 000–20 000 Indian rupees 
(US$200–400); and high-income strata, greater than 20 000 
Indian rupees (US$400). We categorised highest educa-
tion level attained into three categories: up to primary, 
secondary schooling and graduates. The marital status was 
classified as single, married, widowed and divorced. Body 
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mass index (kg/m2) international classification of ≤17.9 
was used to define underweight, 18.0–24.9=normal weight, 
25.0–29.9=overweight and ≥30.0= obese. Lifestyle habits 
like tobacco use were classified based on self-reports as 
never, former and current user. Data on chronic conditions 
consisted of self-reported hypertension, diabetes, heart 
disease, stroke and kidney disease. In addition, diabetes was 
categorised into self-reported, newly diagnosed (defined 
by no self-reported diabetes and FBG of ≥126 mg/dL or 
HbA1c ≥6.5%), pre-diabetes (no self-reported diabetes and 
FBG ≥100–125 mg/dL or HbA1c ≥5.7%–6.4%) and normo-
glycaemia (no self-reported diabetes and FBG <100 mg/dL 
and HbA1c <5.7%). Similarly, we classified hypertension 
as self-reported, newly diagnosed (no self-reported hyper-
tension and BP ≥140/90 mm Hg), prehypertension (no 
self-reported hypertension and BP 120–139/80–89 mm Hg) 
and normotensive (no history of hypertension and 
BP <120/80 mm Hg).
ethical considerations
Study participants provided written informed consent 
before participation in the study.
Analysis
We used Stata V.14.0 for data analysis. We used the ‘svy’ 
command for all analysis to account for the complex survey 
design.20 Before any of the survey estimation commands 
were used, the svyset command was used to specify the vari-
ables that described the stratification, sampling weight and 
primary sampling unit variables. This analysis included data 
obtained from 16 284 study participants. All the responses 
coded as refused, unknown or missing were treated as 
missing data. The frequency (percentages) and mean were 
reported to display the level of population health status and 
the sample characteristics. Percentages of those reporting 
any problems in EQ5D domains and mean VAS were strat-
ified by respondents’ demographic characteristics—age, 
gender, marital status and SES—education, income and 
employment status; and health-related indicators—pres-
ence of chronic conditions—were reported. Additionally, 
prevalence ratios of moderate or severe health problems 
in people with and without chronic conditions were esti-
mated using log binomial regression. Where the model did 
not reach convergence, Poisson regression model was used. 
The model was adjusted for sociodemographic covariates 
(age, gender, marital status, education level and household 
income) and city. Linear regression analysis was performed 
to explore the relationship between the VAS and the EQ5D 
measures across major subgroups. In the regression model, 
VAS was used as a dependent variable, and EQ5D measures 
were treated as independent variables.
STudy ReSulTS
Characteristics of the study population
A total of 17 274 individuals in 10 002 households were 
approached in the three study sites (7596 participants 
in Chennai, 5420 in Delhi, 4258 in Karachi). From 
these, a total of 16 287 participants were recruited (the 
overall response rate was 94.3% at the participant level: 
6906 Chennai (90.9%), 5364 Delhi (98.9%) and 4017 
Karachi (94.3%)). Detailed baseline characteristics of 
the CARRS cohort are published elsewhere.21–24 Briefly, 
the mean age was 42.4 (±13.3), 52.4% were female, 
61% completed secondary schooling and the majority 
of respondents (72.5%) reported household income 
level <10 000 Indian rupees (US$200). Two-thirds (66%) 
of the study population had BMI ≥25, one-fifth (20%) 
of the respondents reported current tobacco use, and 
37.5% had self-reported chronic conditions (hyperten-
sion, diabetes, heart disease, stroke or chronic kidney 
disease).
Overall hRQOl by age and gender
A total of 16 284 study participants completed the 
EQ5D-VAS (99.9%). Overall, the percentage of respon-
dents reporting any problems in mobility and pain/
discomfort (14% each) was higher than for other 
domains. Greater health problems were observed with 
higher age for both men and women (p<0.001) (table 1). 
Problems with mobility were higher with advancing age. 
However, problems with anxiety/depression did not show 
such trend. Average health status (VAS) reported by the 
CARRS cohort was 74.5 (95% CI 73.7 to 74.2) (figure 1). 
Women reported lower health status than men (71.6 vs 
79.0; p<0.001).
Of the respondents 74% rated a perfect health profile 
with no difficulties in any EQ-5D domain, and 0.06% rated 
the worst health profile whereby they had difficulties with 
every EQ-5D domain. The distribution of the VAS scores 
was skewed in the direction of best-imagined health state. 
Only 0.5% respondents rated their health status on VAS 
under 10, and 10% rated it under 50 (online supplemen-
tary appendix 1).
hRQOl and SeS
Table 2 and Figure 2 depict the mean VAS, percentage 
and prevalence ratios of respondents reporting moderate 
or severe problems in the five dimensions, across various 
subgroups, respectively. Employed adults and students 
reported better health status than home makers, retired 
or unemployed participants. We observed almost equal 
health status in home makers and retired people. Health 
status was also similar in the middle-income and high-in-
come groups, while it was significantly lower in the low-in-
come group. Individuals with higher education (graduate 
and above) and high income had higher HRQOL than 
those with secondary or primary schooling and low-in-
come class. Also, individuals with BMI ≥18–24 kg/m2 
reported better health status than those with BMI ≥25 kg/
m2. Current tobacco users reported better health status 
than former tobacco users or non-users. However, in a 
stratified analysis of HRQOL in tobacco users by pres-
ence or absence of chronic conditions, tobacco users with 
chronic conditions reported worse health status than 
non-users.
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hRQOl and chronic conditions
Overall, individuals with chronic conditions reported 
lower health status than those without chronic condi-
tions. About half of the respondents with self-reported 
diabetes, hypertension, stroke, heart disease or chronic 
kidney disease reported moderate or severe problems in 
all five domains (table 2).
Table 3 presents the adjusted prevalence ratio of 
moderate or severe problems among people with versus 
without chronic conditions, stratified by sex and cities. 
Individuals with chronic conditions reported two times 
greater problems in mobility, usual activities domains, 
pain/discomfort and anxiety/depression, than in indi-
viduals without chronic conditions.
Further, a small proportion of individuals with chronic 
conditions, mostly those with hypertension (10.5%) or 
diabetes (8.3%), reported having a perfect health state.
Relationship between VAS and eQ5d measures across major 
subgroups
We expected that each EQ5D dimension would have an 
independent relationship with VAS since each of them 
represents a different aspect of HRQOL. Online supple-
mentary appendix 2 provides the beta coefficients of the 
weighted regression models (ie, with the application of 
the population sampling weights). In the overall popu-
lation, having any problems in mobility, self-care, pain/
discomfort and anxiety/depression were associated with 
VAS scores that were 10–12 points lower. This inverse 
relationship of lower VAS with higher domain difficulties 
was larger in men, elderly (>60 years), low-income, less 
educated, divorced and high BMI individuals, compared 
with their respective counterparts. Tobacco users who 
reported difficulties in all domains of EQ5D had lower 
VAS scores (indicating lower quality of life). Kidney 
disease and stroke were the most disabling conditions on 
all measures.
dISCuSSIOn
Comparative assessments of HRQOL variations by socio-
demographic factors and chronic conditions aid in prior-
itising public health targets for intervention. Results from 
this study indicate that less than 10% of the respondents 
rated their health status as 100 (ie, best-imagined health 
state) on VAS. Mobility, pain/discomfort and anxiety/
depression were the most commonly reported problems, 
with the extent of these problems differing across popula-
tion subgroup. Elderly (>60 years) and women reported 
significantly greater problems in the mobility, pain/
discomfort and anxiety/depression domains.
The mean VAS in our study was 74.5, which is lower 
than reported by most Western countries (82.5), but 
comparable to the results from other low-income 
and middle-income countries (LMIC) (71.1–77.8) 
(online supplementary appendix 3).25–28 Lower health 
status reported by urban South Asians can be interpreted 
in a number of ways. The lower scores may be related E
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to generally lower reporting of HRQOL among this 
group. Alternatively, these scores may reflect morbidity 
and suboptimal access to healthcare facilities to address 
health concerns. South Asians experience chronic condi-
tions at relatively younger ages than other race/ethnic 
groups, and the associated reductions in productivity and 
income levels may be manifested in these self-reported 
EQ5D-VAS scores.
A higher percentage of individuals reported problems 
in mobility dimension (14%–17%) in South Asia, which 
is comparable to results from other LMICs.29 However, 
problems in anxiety/depression are pretty low in South 
Asia when compared with the rest of the world; this could 
be due to underdiagnoses of depression-related prob-
lems or stigma attached to these health conditions. These 
patterns could also reflect differences in how adults in 
different parts of the world self-rate their health.
Worse health status in retired or home makers, 
compared with employed persons, may be related to 
being homebound or reflect underlying illnesses that 
may be the factor driving these participants to be home-
bound and not employed.
In terms of modifiable risk factors, maintaining a 
healthy BMI cut-off (18–25 kg/m2) is favoured because 
individuals with BMI <18 kg/m2 and ≥25 kg/m2 reported 
greater problems in all five domains. Although previous 
studies have shown that lower levels (intensity) of tobacco 
use are linked with higher HRQOL and regular tobacco 
users with worse health status,30 31 in our study, former 
tobacco users reported lower HRQOL than current users. 
This finding may indicate reverse causality, that is, former 
tobacco users after experiencing an illness would have 
quit smoking/tobacco. Further, supported by the fact that 
tobacco users with chronic conditions or greater difficul-
ties in EQ5D domains had lower VAS scores is suggestive 
that morbidity and not the habit of tobacco use per se is 
more closely related to participants’ perception of health. 
However, a causal link between tobacco use and HRQOL 
cannot be confirmed in this cross-sectional study. Longi-
tudinal analyses of the independent associations between 
the smoking/tobacco with HRQOL may provide a better 
understanding of this relationship.
Notably, one in five individuals living with known hyper-
tension or diabetes (average disease duration 4 years) 
still reported a perfect health state, indicating that these 
individuals may feel asymptomatic until they experience 
a clinical event. Also, very small proportions of patients 
with heart disease and stroke (with longer duration of 
illness; average 9 years) reported perfect health states, 
suggesting that these individuals may have adapted to 
their conditions over time and may be benefiting from 
treatment and self-care that improve their self-rated 
quality of life. However, we did not investigate whether 
these other factors like adherence influence quality of life 
in those living with chronic conditions.
Due to the differences in statistical analyses, HRQOL 
measures, sociodemographic characteristics of the 
sample and medical conditions selected, the results of 
this study may not be directly comparable to reports from 
other countries.32 Nevertheless, a few differences and 
common findings are noteworthy. Individuals with stroke 
or chronic kidney disease rated the lowest health status, 
Figure 1 Mean self-rated health status using the European Quality of Life Five Dimension—Visual Analogue Scale (EQ5D-VAS) 
of respondents by age groups and gender. This figure presents the mean self-rated health status for overall study population 
by age groups and gender. The EQ5D-VAS measures health status on a scale of 0 (worst health status) to 100 (best imaginable 
health status). *p Value for difference between mean EQ5D-VAS between men and women at each age group is statistically 
significant, p<0.01.
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which is consistent with results reported from other 
studies done in China, Thailand and Western popula-
tions.28 33–36 Since the respondent’s health status could be 
affected by how well the condition was managed, caution 
is needed in interpreting study results regarding the rela-
tive effect of chronic conditions on HRQOL.37–41 A more 
Figure 2 PR of moderate or severe health problems by sociodemographic factors and chronic conditions. (A) Shows 
the PR of moderate or severe difficulties in EQ5D domains (mobility, self-care, usual activities, pain/discomfort, anxiety/
depression and any of the five dimensions) by employment status. With reference to those who were employed (PR=1), 
housewife, retired and the unemployed reported greater problems in all five domains, whereas students only reported 
higher anxiety problems compared with employed. (B) Shows the PR of moderate or severe difficulties in EQ5D domains 
by income group. With reference to low-income group (PR=1), those in middle-income or high-income groups had less 
problems in all five domains. (C) Shows the PR of moderate or severe difficulties in EQ5D domains (mobility, self-care, usual 
activities, pain/discomfort, anxiety/depression and any of the five dimensions) by education level. With reference to those 
primary school education (PR=1), individuals with secondary school or graduates reported significantly lower problems in all 
five domains. (D) Shows the PR of moderate or severe difficulties in EQ5D domains by marital status. With reference to single 
(PR=1), those who were married, widower or divorcee had greater problems in all five domains. (E) Shows the PR of moderate 
or severe difficulties in EQ5D domains (mobility, self-care, usual activities, pain/discomfort, anxiety/depression and any of the 
five dimensions) by BMI. With reference to underweight, that is, BMI <18 kg/m2 (PR=1), individuals who are overweight (BMI 25–
29.9 kg/m2) or obese (BMI ≥30 kg/m2) reported significantly greater problems in all five domains. (F) Shows the PR of moderate 
or severe difficulties in EQ5D domains by chronic conditions. Compared with those without chronic conditions, individuals 
with self-reported diabetes, hypertension, heart disease, stroke and kidney disease had twice greater problems in all five 
domains. AD, any dimension; BMI, body mass index; EQ5D, European Quality of Life Five Dimension; HRQOL, health-related 
quality of life; PR, prevalence ratio; SC, self-care; UA, usual activities.
 o
n
 14 August 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018424 on 15 October 2017. Downloaded from 
10 Singh K, et al. BMJ Open 2017;7:e018424. doi:10.1136/bmjopen-2017-018424
Open Access 
Ta
b
le
 3
 
A
d
ju
st
ed
 P
R
 o
f r
ep
or
tin
g 
an
y 
p
ro
b
le
m
s 
in
 in
d
iv
id
ua
ls
 w
ith
 c
hr
on
ic
 c
on
d
iti
on
s 
ve
rs
us
 t
ho
se
 w
ith
ou
t 
ch
ro
ni
c 
co
nd
iti
on
s,
 b
y 
ci
tie
s 
an
d
 g
en
d
er
M
o
b
ili
ty
S
el
f-
ca
re
U
su
al
 a
ct
iv
it
ie
s
P
ai
n/
D
is
co
m
fo
rt
A
nx
ie
ty
/D
ep
re
ss
io
n
A
ny
 d
im
en
si
o
n
P
R
95
%
 C
I
P
R
95
%
 C
I
P
R
95
%
 C
I
P
R
95
%
 C
I
P
R
95
%
 C
I
P
R
95
%
 C
I
O
ve
ra
ll*
1.
41
[1
.2
7 
to
 1
.5
7]
1.
35
[1
.0
9 
to
 1
.6
7]
1.
70
[1
.4
5 
to
 2
.0
1]
1.
74
[1
.5
8 
to
 1
.9
1]
1.
60
[1
.4
0 
to
 1
.8
4]
1.
45
[1
.3
5 
to
 1
.5
6]
 
 M
al
e†
1.
78
[1
.4
6 
to
 2
.1
8]
1.
60
[1
.1
0 
to
 2
.3
4]
2.
01
[1
.4
1 
to
 2
.8
7]
1.
89
[1
.6
2 
to
 2
.2
3]
2.
01
[1
.5
5 
to
 2
.6
2]
1.
63
[1
.4
1 
to
 1
.8
8]
 
 Fe
m
al
e†
1.
32
[1
.1
6 
to
 1
.5
0]
1.
28
[0
.9
9 
to
 1
.6
6]
1.
67
[1
.4
0 
to
 1
.9
9]
1.
72
[1
.5
3 
to
 1
.9
3]
1.
44
[1
.2
3 
to
 1
.6
9]
1.
39
[1
.2
9 
to
 1
.5
2]
C
he
nn
ai
‡
1.
24
[1
.0
5 
to
 1
.4
6]
1.
08
[0
.8
4 
to
 1
.4
0]
1.
31
[1
.0
7 
to
 1
.6
0]
1.
71
[1
.4
5 
to
 2
.0
4]
1.
56
[1
.3
1 
to
 1
.8
6]
1.
30
[1
.1
7 
to
 1
.4
4]
 
 M
al
e†
1.
46
[1
.0
7 
to
 1
.9
9]
1.
12
[0
.7
1 
to
 1
.7
6]
1.
24
[0
.8
0 
to
 1
.9
0]
1.
73
[1
.3
4 
to
 2
.2
4]
1.
75
[1
.3
4 
to
 2
.3
0]
1.
38
[1
.1
6 
to
 1
.6
6]
 
 Fe
m
al
e†
1.
18
[0
.9
7 
to
 1
.4
4]
1.
08
[0
.7
9 
to
 1
.4
7]
1.
38
[1
.1
1 
to
 1
.7
3]
1.
73
[1
.3
8 
to
 2
.1
7]
1.
46
[1
.1
6 
to
 1
.8
3]
1.
27
[1
.1
2 
to
 1
.4
5]
D
el
hi
‡
1.
66
[1
.4
1 
to
 1
.9
5]
3.
05
[1
.7
8 
to
 5
.2
5]
2.
40
[1
.6
6 
to
 3
.4
7]
1.
79
[1
.5
4 
to
 2
.0
8]
1.
84
[1
.2
9 
to
 2
.6
3]
1.
65
[1
.4
7 
to
 1
.8
6]
 
 M
al
e†
2.
13
[1
.5
2 
to
 2
.9
7]
5.
14
[1
.9
2 
to
 1
3.
78
]
3.
63
[1
.6
1 
to
 8
.1
7]
1.
93
[1
.5
0 
to
 2
.4
9]
3.
45
[1
.3
6 
to
 8
.8
0]
1.
89
[1
.4
5 
to
 2
.4
8]
 
 Fe
m
al
e†
1.
58
[1
.3
1 
to
 1
.9
0]
2.
23
[1
.2
7 
to
 3
.9
4]
2.
15
[2
.1
5 
to
 2
.1
5]
1.
82
[1
.5
1 
to
 2
.1
8]
1.
56
[1
.1
2 
to
 2
.1
8]
1.
62
[1
.4
3 
to
 1
.8
3]
K
ar
ac
hi
‡
1.
41
[1
.1
5 
to
 1
.7
2]
1.
77
[1
.0
5 
to
 3
.0
0]
2.
09
[1
.5
8 
to
 2
.7
7]
1.
64
[1
.3
7 
to
 1
.9
7]
1.
60
[1
.2
1 
to
 2
.1
1]
1.
43
[1
.2
5 
to
 1
.6
5]
 
 M
al
e†
2.
51
[1
.5
2 
to
 4
.1
3]
1.
76
[0
.7
7 
to
 4
.0
2]
2.
91
[1
.6
2 
to
 5
.2
2]
2.
28
[1
.5
2 
to
 3
.4
2]
2.
04
[1
.2
7 
to
 3
.2
9]
2.
01
[1
.4
4 
to
 2
.8
0]
 
 Fe
m
al
e†
1.
24
[1
.0
1 
to
 1
.5
3]
2.
11
[1
.1
0 
to
 4
.0
4]
1.
95
[1
.4
4 
to
 2
.6
5]
1.
50
[1
.2
4 
to
 1
.8
1]
1.
32
[0
.9
4 
to
 1
.8
7]
1.
27
[1
.1
0 
to
 1
.4
7]
P
re
va
le
nc
e 
ra
tio
s 
(P
R
s)
 w
er
e 
es
tim
at
ed
 u
si
ng
 P
oi
ss
on
 r
eg
re
ss
io
n 
m
od
el
  a
s 
th
e 
lo
g 
b
in
om
ia
l r
eg
re
ss
io
n 
m
od
el
 d
id
 n
ot
 r
ea
ch
 c
on
ve
rg
en
ce
.
*A
d
ju
st
ed
 fo
r 
ag
e,
 s
ex
, i
nc
om
e,
 e
d
uc
at
io
n,
 m
ar
ita
l s
ta
tu
s 
an
d
 c
ity
.
†A
d
ju
st
ed
 fo
r 
ag
e,
 in
co
m
e,
 e
d
uc
at
io
n,
 m
ar
ita
l s
ta
tu
s 
an
d
 c
ity
.
‡A
d
ju
st
ed
 fo
r 
ag
e,
 s
ex
, i
nc
om
e,
 e
d
uc
at
io
n 
an
d
 m
ar
ita
l s
ta
tu
s.
 o
n
 14 August 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018424 on 15 October 2017. Downloaded from 
 11Singh K, et al. BMJ Open 2017;7:e018424. doi:10.1136/bmjopen-2017-018424
Open Access
recent Canadian study conducted by Mo et al42 indicated 
a strong relationship between low Health Utility Index 
scores and certain chronic conditions. The authors found 
that arthritis/rheumatism, heart disease, hypertension, 
cataracts and diabetes had a negative impact on HRQOL. 
In the USA, Medical Expenditure Panel Survey data-based 
study reported that, after adjusting for sociodemographic 
variables, all of the selected chronic conditions were asso-
ciated with lower EQ5D scores, with effects greatest for 
emphysema, followed by heart disease, stroke, high BP, 
diabetes and asthma.43 44
Strengths and limitations of this study
To our knowledge, this is the first population-level 
HRQOL data from South Asia using EQ5D-VAS including 
three large metropolitan cities in India and Pakistan 
with a large sample size that has used multistage cluster 
random sampling strategy and standardised protocols 
and measurement tools across sites. Our data provide the 
first baseline values to be used for monitoring popula-
tion health status and analysed the relationships between 
selected chronic conditions and HRQOL. This informa-
tion could be used to complement national targets by 
providing a measure of chronic disease burden based on 
perceived health status rather than solely on mortality 
and disease prevalence. In our secondary data analysis, 
EQ5D and VAS measures correlated well, which confirms 
the convergent and discriminate validity of the EQ5D 
instrument.
There are several limitations to this study. First, due 
to the cross-sectional nature of the data, the causal rela-
tionship between socioeconomic parameters/chronic 
conditions and HRQOL cannot be determined and is 
not implied. Second, many chronic conditions (respira-
tory, locomotor, cancer and others) were not included in 
the survey. Therefore, the ranking of most severe health 
conditions and associated HRQOL is not complete. Third, 
the selected chronic conditions were self-reported, and 
the study investigators did not examine the accuracy of 
information. However, this poses less of a threat to validity 
because self-reporting of heart diseases, stroke and kidney 
diseases is pretty accurate in community surveys.45–48 
Further, hypertension and diabetes were measured in 
this study using standardised methods. Lastly, EQ5D data 
were self-reported and the variation in how individuals 
perceive disability varies widely. However, this should be 
less of a problem given the large sample size in this study. 
Fourth, the findings of this study may not be replicable 
if researchers use a different HRQOL instrument,49–54 
which can be tested in a future study.
Public health relevance and policy implications
HRQOL data from this study provide baseline values for 
monitoring variations in health for specific population 
groups on the basis of gender, education, employment, 
income, presence of chronic conditions and place of resi-
dence. These data are also relevant to assess the overall 
burden of physical and mental health problems that are 
not disease-specific. In aggregate form, such information 
could be used to complement national health targets by 
providing a measure based on health status (quality of 
life) rather than mortality or disease prevalence alone. 
Therefore, the policy makers can use the HRQOL 
measures and the resulting data from this study to mini-
mise health disparities and allocate resources among 
competing health programme based on burden of phys-
ical or mental health problems in a specific group.55
The lower health status reported by female, less 
educated, unemployed and low-income groups may 
indicate higher levels of stress in these groups.17 Other 
potential contributing factors that are known to influ-
ence health status are living conditions, gross domestic 
product per capita, inequities in income distributions 
and access to healthcare.56–61 Therefore, public health 
initiatives should focus on intersectoral approaches to 
address issues of education, generating more avenues 
for employment and improving the quality and access of 
primary healthcare.
Lastly, the issue of ‘clinical’ or ‘policy’ relevance of the 
difference in EQ5D measures needs much discourse. For 
example, if the VAS in two groups of the population is 5 
or 10 points different from each other, we cannot make a 
clinical judgement on how much these two groups would 
differ in their actual health status. These issues relate to 
determining a minimally significant difference/change 
in HRQOL and needs investigation in future studies. 
However, because of HRQOL sensitivity to time trends 
as shown in previous studies,62–64 these measures are also 
likely to be useful in determining the effect of major 
population-based policies or interventions.
COnCluSIOn
HRQOL appears to be lower with higher age and among 
women in South Asia. Our data demonstrate significantly 
lower HRQOL in key demographic groups and those with 
chronic conditions, which are consistent with previous 
studies. These data provide insights on inequalities in 
population health status, and potentially reveal unmet 
needs in the community to guide health policies.
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